Skip to main content

Table 1 Subject characteristics and main outcome.

From: Equal antipyretic effectiveness of oral and rectal acetaminophen: a randomized controlled trial [ISRCTN11886401]

 

TOTAL

RECTAL (15 MG/KG)

ORAL (15 MG/KG)

RECTAL (35 MG/KG)

Total

51

18

16

17

Male Gender

    

N (%)

29 (56.9)

11

8

10

Age (years):

    

Mean (SD)

4.1 (3.5)

3.8 (2.8)

4.0 (3.6)

3.5 (3.0)

Range

0.5–13.1

0.6–13.1

0.5–10.2

0.5–12.4

Diagnosis:¶ N (%)

    

Pneumonia

10 (19.6)

3

2

5

UTI

7 (13.7)

2

4

1

Virus

17 (33.3)

6

4

7

Bacteremia

5 (9.8)

2

2

1

Others

36 (70.5)

15

12

9

Previous antipyretic

    

N (%)

    

Acetaminophen

40(78.4)

15

14

11

Ibuprofen

8(15.6)

2

2

4

Antibiotic intake

    

N (%)

35 (68.6)

16

8

11

Acetaminophen Dose (mg/kg):

    

Mean (SD) §

 

14.1(2.3)

15.0(0.0)

31.7(6.7)

Range

 

10.7–18.5

15.0–15.0

12.5–43.4

Duration of fever (days):

    

Median

3.0

3

1.3

5

Range

0.5–101.0

1.0–90.0

0.5–15.0

1.0–101.0

Baseline temperature

    

Mean (SD)

39.2 (0.7)

39.1 (0.9)

39.3 (0.6)

39.1 (0.6)

Time to max AP in hr:

    

Mean

3.6

3.3

3.6

3.9

95% CI

3.2–4.0

2.4–4.2

2.8–4.3

3.3–4.6

  1. § P = 0.000 (ANOVA); ¶ Percentages do not add up to 100 since more than one diagnosis is entered for some subjects; max AP: maximum antipyresis; hr: hour.